Oxford BioDynamics Plc (OBD.L) | Stock Information | Vox Markets
Vox Markets
OBD:LN

Oxford BioDynamics Plc

OBD:LN

Latest Coverage

Company Research • Dec 16, 2025

Hybridan Small Cap Feast: 16 December 2025

Share:
Q&A • Dec 5, 2025

Vox Markets Weekly Wrap

Share:
Analyst Comment • Oct 22, 2025

Hybridan Small Cap Feast: 22 October 2025

Share:
Company Research • Mar 13, 2025

Hybridan Small Cap Feast: 13/03/2025

Share:

Overview

Company Profile

We are a biotechnology company with a proprietary epigenetic biomarker discovery platform, EpiSwitch®, based on the latest advances in regulatory genome architecture and its link to clinical outcomes and patient stratification.

Classification

Sector Healthcare

Industry Biotechnology & Life Sciences

Subindustry Biotechnology

Financials

News & Media

Latest Coverage

Dec 16, 2025 • Company Research - Hybridan Small Cap Feast: 16 December 2025
Dec 5, 2025 • Q&A - Vox Markets Weekly Wrap
Oct 22, 2025 • Analyst Comment - Hybridan Small Cap Feast: 22 October 2025
Mar 13, 2025 • Company Research - Hybridan Small Cap Feast: 13/03/2025
Feb 28, 2025 • Company News - Today's Top RNS's on Vox Markets: Rightmove, Andrada Mining, Oxford BioDynamics & More
Feb 12, 2025 • Vox Newswire - Oxford BioDynamics partners with Regina Maria to bring EpiSwitch cancer tests to Romania
Dec 16, 2024 • Company News - Oxford Biodynamics CEO resigns as it seeks short-term funding

Corporate